Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Dr Amanda Pearce, a lecturer in the Department of Chemistry at Loughborough University, has been awarded funding by the ...

Dr Amanda Pearce, a lecturer in the Department of Chemistry at Loughborough University, has been awarded funding by the Academy of Medical Sciences to tackle dementia, as part of its initiative to ...

In a significant advancement, researchers from the Nanoscience Center (NSC) at the University of Jyväskylä, Finland, have ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

MUNICH, Germany & BASEL, Switzerland I April 07, 2025 I Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Researchers have unveiled innovative, label-free ratiometric fluorosensor designed for the selective and sensitive detection of enteroviral RNA. The research promises to deliver even more advanced and ...

PLC (LON:4BB – Get Free Report) insider Heikki Lanckriet purchased 2,400 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was acquired at an average ...

In a significant advancement, researchers from the Nanoscience Center (NSC) at the University of Jyväskylä, Finland, have ...